An unsuspected complication with immune checkpoint blockade: a case report

by Lucia Carril-Ajuria, Elisabeth Jiménez-Aguilar, Carlos Gómez-Martín, Carmen Díaz-Pedroche
Published 2018-09-01

Efficacy and safety of anti-PD-1/PD-L1 combinations versus standard of care in cancer: a systematic review and meta-analysis.

by Alberto Carretero-González, Irene Otero, David Lora, Lucía Carril-Ajuria, Daniel Castellano, Guillermo de Velasco
Published 2021-01-01

Immune Checkpoint Inhibitor Combination Therapy versus Sunitinib as First-Line Treatment for Favorable-IMDC-Risk Advanced Renal Cell Carcinoma Patients: A Meta-Analysis of Randomiz...

by Ray Manneh, Mauricio Lema, Lucía Carril-Ajuria, Linda Ibatá, Susan Martínez, Daniel Castellano, Guillermo de Velasco
Published 2022-03-01

B cells and the coordination of immune checkpoint inhibitor response in patients with solid tumors

by Jean-Yves Scoazec, Francois-Xavier Danlos, Laurence Albiges, Bernard Escudier, Ronan Flippot, Lydie Cassard, Nathalie Chaput, Natacha Naoun, Marie Naigeon, Jean-Mehdi Jouniaux, Lisa Boselli, Lucia Carril-Ajuria, Marcus Teixeira, Macarena Rey-Cardenas, Larissa Rainho
Published 2024-04-01

Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with...

by Laurence Albiges, Bernard Escudier, Catherine Sautes-Fridman, Benoit Beuselinck, Lydie Cassard, Maxime Meylan, Nathalie Rioux-Leclercq, Aude Desnoyer, Guillaume Lacroix, Nathalie Chaput-Gras, Marie Naigeon, Lisa Boselli, Salem Chouaib, Lucia Carril-Ajuria, Cécile Dalban, Yann Vano, Sylvie Chabaud, Janice Barros-Monteiro, Antoine Bougoüin, Irelka Colina-Moreno, Florence Tantot, Caroline De Oliveira, Wolf Herve Fridman
Published 2022-05-01